Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · IEX Real-Time Price · USD
3.820
-0.050 (-1.29%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $226.96 million as of July 22, 2024. Its market cap has decreased by -50.07% in one year.
Market Cap
226.96M
Enterprise Value
109.58M
1-Year Change
-50.07%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $226.96M, an increase of 510.12%. That is a compound annual growth rate of 19.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 227.00M | 9.93% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 229.93M |
| 2seventy bio | 229.78M |
| NeuroPace | 228.99M |
| Delcath Systems | 228.68M |
| ESSA Pharma | 228.03M |
| Acrivon Therapeutics | 226.33M |
| Butterfly Network | 225.46M |
| 23andMe Holding Co. | 223.75M |